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Abstract 
 
Background: Toxoplasma gondii is a zoonotic parasite that has arisen as an important opportunistic infection that causes 
morbidity and mortality especially in HIV positive patients. This study was carried out to determine the sero-prevalence of 
T. gondii (IgG and IgM) and the associated risk factors among HIV positive and negative patients in Northern South Africa.  
Materials and Methods: The study was conducted in the Vhembe District in Limpopo province from April 2012 to 
January 2013. A well-structured questionnaire was used to collect socio-demographic information and possible risk factor 
information on toxoplasmosis from participants. A total of 161 blood samples of both HIV positive and negative patients 
visiting the local clinics in the Vhembe district were collected. Serum samples were tested for IgG and IgM against T. 
gondii using commercially available ELISA protocol.  
Results: The prevalence of T. gondii IgG was 31.7% while that of T. gondii IgM was 4.9%. The prevalence of T. gondii 
IgG was higher in HIV positive patients (38%) compared to 16.7% among HIV negative patients (p=0.001). Toxoplasma 
gondii IgG antibodies were more common in patients who were not taking ARV’s (46.2%) compared to those who were 
taking ARV’s (35.2%) (P<0.001).  
Conclusions: The present study has shown a high prevalence of T. gondii (IgG) among patients attending different HIV 
clinics in the Vhembe district with no current infections among pregnant women. In addition to the sero-positive status of 
the patient to HIV, other significant risk factors for toxoplasmosis included high viral load, non-adherence to ARV therapy 
and age (>25 years).  
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Introduction 
 
Toxoplasma gondii is a zoonotic intracellular parasite that causes the disease toxoplasmosis (Kopecna et al., 2006). 
The infection is very common in humans around the world (Lim and Othman, 2014). In immuno-competent individuals, the 
symptoms may be mild or remain asymptomatic while it causes high rates of morbidity and mortality in 
immunocompromised individuals (Shen et al., 2016).  Toxoplasmosis is one of the most important opportunistic infections 
detected in HIV patients. According to the U.S centres for disease control and prevention, Toxoplasmosis is an AIDS- 
defining illness. In HIV infection, toxoplasmic encephalitis occurs due to reactivation of latent Toxoplasma infection 
(Daryani et al., 2011). However, the epidemiology of toxoplasmosis is not clearly understood in the Northern region of 
South Africa. 
The prevalence of toxoplasmosis varies between regions and is higher in areas where cats are common (Prestrud et 
al., 2010; Dubey et al., 2016). In South Africa, Harri et al. (2007) reported a prevalence of 8% infection with T. gondii 
among HIV patients in Johannesburg, whereas another study in the Limpopo province, north of the country, reported a 
higher prevalence (18.1%) among chronically ill HIV patients (Bessong and Mathomu, 2010). However, both studies did 
not test for IgM antibodies. In Brazil, the prevalence of Toxplasma IgG was 16% among pregnant women while that of IgM 
was 1% in the same population (de Quadros et al., 2015). Moreover, in an Ethiopian study, the seroprevalence was found to 
be 60% and 64% in females and males respectively (Negash et al., 2008). However, they also did not test for T. gondii IgM 
antibodies. 
Exposure to Toxoplasma is shown by the detection of Toxoplasma IgG while IgM indicates current infections 
(Gashout et al., 2016). These infections might be more relevant as they indicate the level of epidemic in a specific 
community. Current infections among pregnant women are dangerous and could lead to malformation of the newborn or its 
death (Dubey et al., 2016). Although previous studies have shown that the prevalence of Toxoplasma IgG in South Africa 
varies between 8% and 16%, very few studies have reported on the prevalence of current infections particularly in the 
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northern part of South Africa. Therefore, the present study sought to determine T. gondii IgG and IgM seroprevalence 
among patients visiting the HIV clinics in the Vhembe region and to identify factors that might be associated with T. gondii 
in the region.  
 
Materials and Methods 
Study participants and design 
 
The study was a cross sectional survey of patients visiting HIV clinics at different hospitals in the region and the 
University of Venda. It was conducted in the Vhembe district in Limpopo province from April 2012 to January 2013. A 
well-structured questionnaire was used to collect socio-demographic information and possible risk factor information on 
toxoplasmosis from participants. A total of 161 blood samples were collected from HIV positive (118) and negative (43) 
patients from the three main hospitals in the Vhembe district, Limpopo Province (Elim, Donald Fraser and Tshilidzini). 
Some of the samples were collected from the students attending the University of Venda. The samples were transported in 
cooler boxes filled with ice to the laboratory of Microbiology at the University of Venda for further analysis. Plasma was 
obtained following centrifugation of blood samples and stored at -20ºc until further use.   
 
Serological testing for toxoplasmosis 
 
The presence of T. gondii IgG and IgM antibodies in the serum samples was determined by the ELISA method. 
The test was done using the bioelisa TOXO IgG and TOXO IgM kits (BIOKIT, S.A, Barcelona- Spain) as per the 
manufacturer's instructions. The optical densities (OD) values were read using ELISA reader (Bio-Tek INSTRUMENTS, 
INC) at 450nm and the results were recorded. 
  
Ethical considerations 
 
The health and ethics committee of the University of Venda approved the study. Ethical clearance was also 
obtained from the different hospitals where the samples were collected. The objectives of the study were clearly explained 
to the sample providers and they were requested to sign the consent forms before data and sample collection. The 
information obtained from the patients was kept confidential. 
 
Statistical analysis 
 
The data obtained was analysed using SPSS version 18.1. The chi square test was used for all analysis comparing 
the prevalence of toxoplamosis among the patients according to different demographic characteristics as well as different 
potential risk factors. The difference was considered significant if the p value was less than 0.05. 
 
Results 
Socio- demographic and clinical characteristics of the study population 
 
Most of the patients tested for Toxoplasma antibodies in the present study, were HIV positive 118 (73.3%) while 
34 (26.7%) were HIV negative. Most of them were from Donald Fraser (41%), and 64% of the patients were females [Table 
1].  
 
Table 1: Demographic characteristics of the study population 
 
Characteristics Frequency Percent 
HIV status 
HIV negative 43 26.7 
HIV positive 118 73.3 
Hospital 
Donald Fraser 66 41.0 
Elim 12 7.5 
LTT 15 9.3 
Tshilidzini 25 15.5 
Univen 43 26.7 
Age group 
Less than 25 years 39 26.5 
25 years- 45 years 65 44.2 
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Above 45 years 43 29.3 
Gender 
Male 54 36.0 
Female 96 64.0 
Marital 
Status 
Single  81 54.0 
Married  49 32.7 
Divorced  8 5.3 
 
The occurrence of T. gondii IgG in patients in relation to HIV status, place of infection, hospitals, age, gender and 
marital status of the patients. 
 
The antibodies (IgG) against T. gondii were more common in HIV infected patients (38%) compared to HIV 
negative patients (16.7%) and the difference was statistically significant (χ2=6.218, p= 0.013).  Patients recruited at Elim 
hospital had a higher prevalence (54.5%) compared to other hospitals and University of Venda students had the least 
prevalence among all the sites. The antibodies (IgG) against T. gondii were more detected in patients aged above 45, and 
the least prevalence was found in patients aged 25 or less. In terms of gender, the infection was more commonly detected in 
females (34.1%) than in males (29.8%) and the difference was not statistically significant. The infection was more common 
among patients who indicated that they had obtained the HIV infection in the Vhembe district (42.0%) compared to those 
infected in other places (27.3%) but the difference was not statistically significant (p>0.05) (Table 2). There was no 
difference in the prevalence of IgG among patients receiving prophylaxis and those who were not receiving prophylaxis.  
 
Table 2: The occurrence of T. gondii IgG in patients in relation to HIV status, place of infection, hospitals, age, gender and 
marital status of the patients. 
Variables Characteristics Toxo IgG Positive Total Statistics (χ2, p) 
HIV status 
HIV negative 7 (16.7%) 42 χ2=6.218, p=0.013 
HIV positive 38 (38%) 100  
Hospital 
Donald Fraser 22(40.0%) 55 χ2= 8.963, p=0.062 
Elim 6 (54.5%) 11  
LTT 4 (26.7%) 15  
Tshilidzini 6 (31.6%) 19  
Univen 7 (16.7%) 42  
Agegroup3 
25 or less 6 (16.2%) 37 χ2=7.425, p=0.024 
25- 45 20 (35.1%) 57  
Above 45 16 (45.7%) 35  
Gender 
Male 14 (29.8%) 47 χ2=0.258, p=0.611  
Female  29 (34.1%) 85  
Marital status 
Single  21 (28.8%) 73 χ2=1.258,p= 0.739 
Married  15 (35.7%) 42  
Divorced  3 (42.9%) 7  
Widowed  4 (40.0%) 10  
Infected in Vhembe 
NO 3 (27.3%) 11 χ2=0.871, p=0.351 
YES 34(42.0%) 81  
Year of recruitment 
2010 36 (43.6%) 104 χ2=1.536, p= 0.215 
2011 9 (23.7%) 38  
WAZ less than -2 
Not underweight 36 (30.5%) 118 χ2=2.154, p=0.142 
Underweight 4(57.1%) 7  
Prophylaxis 
NO 23 (38.3%) 60 χ2=0.149, p=0.700 
YES 14 (42.4%) 33  
 
The occurrence of T. gondii -IgG in HIV patients in relation to ARV treatment and CD4 count 
 
Toxoplasma gondii IgG antibodies were more common in patients who were not taking ARV’s (46.2%)[Table 3]. 
No significant difference was observed between the CD4 level (less than 50) and T. gondii IgG titer. The seroprevalence of 
Toxoplasma IgG was much higher (58.3%) among patients with high viral load compared to those with low viral load 
(14.8%) (P=0.005) The patients using alternative medication were not highly infected (33.3%), compared to those who 
were not taking alternative medication (40.2%) although the difference was not significant. In terms of ARV’s used by 
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these patients, tenofovir was found to be the best ARV because of the low Toxo sero-prevalence in people who were taking 
it (29.4%), compared to those using other ARV’s, e. g stavudine, lamivudine, nevirapine and efavirenz. 
 
Table 3: The occurrence of T. gondii IgG in HIV positive patients in relation to ARV treatment and the CD4 status of the 
patients 
Variables Characteristics Toxo IgG Positive Total Statistics 
ARV 
NO 18(46.2%) 39 χ2=1.137, p= 0.286 
YES 19 (35.2%) 54  
Have you stopped 
NO 6 (33.3%) 18  
YES 2(100.0%) 2  
CD4 less than 50 
NO 29 (39.7%) 73 χ2=0.007, p=0.932 
YES 5 (38.5%) 13  
CD4 count Less 
Than 200 
NO 16 (37.2%) 43 χ2=0.195, p=0.659 
YES 18 (41.9%) 43  
CD4 count more 
than 300 
NO 25 (41.7%) 60 χ2= 0.377, p=0.539 
YES 9 (34.6%) 26  
Viral load range 
Low  4(14.8%) 27 χ2=7.770,p=0.005 
High  7 (58.3%) 12  
Bactrim 
NO 28 (38.9%) 72 χ2= 0.107, P=0.744 
YES 9 (42.9%) 21  
Zidovudine 
NO 17(34.7%) 49 χ2= 0.056, P=0.813 
YES 2(40.0%) 5  
Efavirenz 
NO 4 (33.3%) 12 χ2= 0.023, P=0.870 
YES 15 (35.7%) 42  
Lamivudine 
NO 0 (0.0 1 χ2= 0.553, P=0.457 
YES 19(35.8%) 53  
Tenofovir 
NO 14 (37.8%) 37 χ2=0.363,P=0.547 
YES 5 (29.4%) 17  
Nevirapine 
NO 15 (33.3%) 45 χ2= 0.406, P=0.524 
YES 4(44.4%) 9  
Stavudine 
NO 7 (31.8%) 22 χ2=0.185, P=0.667 
YES 12 (37.5%) 32  
 
The prevalence of T. gondii IgG in patients in relation to animal ownership 
 
Patients who admitted keeping animals in their households appeared to be less infected compared to those who did 
not keep animals in the house. Toxoplasma gondii IgG antibodies were more detected in patients who had dogs in their 
homes (40%) [Table 4].  
 
Table 4: The prevalence of T. gondii IgG in patients who kept animals in the house 
Variables Characteristics Toxo IgG Positive Total Statistics (x2, p) 
 
Animals in house 
NO 39 (34.5%) 113 χ2=0.920, p=0.337  
YES 5 (23.8%) 21  
Chicken 
NO 41(33.1%) 124 χ2=0.538, p=0.463 
YES 3 (23.1%) 13  
Cattle 
NO 43 (32.3%) 133 χ2=0.096, p=0.757 
YES 1 (25.0%) 4  
Dogs 
NO 42 (31.8%) 132 χ2=0.148, p=0.701 
YES 2 (40.0%) 5  
Cats 
NO 44 (32.4%) 13 χ2=0.477, p=0.490 
YES 38(23.4%) 13  
Goats 
NO 43 (32.3%) 133 χ2=0.096, p=0.757 
YES 1(25.0%) 4  
 
Ngobeni and Samie, Afr., J. Infect. Dis. (2017) 11 (2): 1-9 
https://doi.org/10.21010/ajid.v11i2.1  
 
5 
 
The occurrence of T. gondii IgG among the patients in relation to water sources 
 
The patients were using water from different sources; some patients were treating their water before use, while 
others were not. No statistically significant difference was noted between those using untreated water as opposed to the 
group of patients using treated water [Table 5]. Toxoplasma gondii IgG antibodies were higher in patients who were storing 
water for a long time (more than 5 days) than those who were storing water for less than 5 days. However, the difference 
was not statistically significant. [Table 5]. 
 
Table 5: The occurrence of T. gondii IgG in relation to the different water sources used 
Variables Characteristics Toxo IgG Positive Total Statistics 
Water source 
Communal tap 31 (30.7%) 101 χ2=1.159, p=0.763 
Tap in the house 9(39.1%) 23  
River/Spring 2 (50.0%) 4  
Borehole 2 (33.3%) 6  
Water storage 
Two days or less 27 (31.0%) 87 χ2=0.30, p=0.866 
3 to 5 days 7 (36.8%) 19  
More than 5 days 9 (34.6%) 26  
Treated Source 
NO 4 (40.0%) 10 χ2=0.251, p=0.616 
YES 40 (32.3%) 124  
Do you treat water 
YES 42 (32.1%) 131 χ2=1.593, p=0.207 
NO 2 (66.7%) 3  
 
Overall T. gondii IgM seroprevalence in the study population 
 
The seroprevalence of T. gondii IgM was much lower compared to that of the IgG at 4.9%. There was no 
significant difference between the seroprevalence of T. gondii IgM among HIV negative (7.1%) and positive individuals 
(3.9%) The infection with T. gondii was more detected in patients from UNIVEN (7.1%), LTT (6.7%) and Donald Fraser 
(5.8%), while those from Elim and Tshilidzini were seronegative (P=0.652) (Table 6). The patients in the age group 25 
years or less, had a high prevalence (7.9%) compared to others in the age groups 26 to 45 years (3.6%) [Table 6]. The 
prevalence was higher in males compared to females and in terms of marital status the prevalence was found to be high in 
divorced patients (12.5%) and those who indicated that they were married had a prevalence of (4.8%). The patients who 
were infected in the Vhembe district had a lower prevalence (2.4%), than those who were infected from other places and 
the difference between these two variables was not statistically significant. There was no difference between the prevalence 
of T. gondii IgM among patients who were recruited in 2010 and 2011. Those who were underweight had a high prevalence 
of 12.5% compared to those who were not underweight (4.1%). In terms of prophylaxis, those who were receiving 
prophylaxis had a low prevalence compared to those who were not receiving. 
 
Table 6: The occurrence of T. gondii IgM in HIV patients from different hospitals, place of infection, age groups, gender 
and marital status of patients. 
Variables Characteristics Toxo IgM Positive Total Statistics 
HIV status 
Negative 3 (7.1%) 42 χ2=0.668, p=0.414 
Positive 4 (3.9%) 102  
Hospital 
Donald Fraser 3 (5.8%) 52 χ2=2.460, p=0.652 
Elim 0 (0.0%) 10  
LTT 1(6.7%) 15  
Tshilidzini 0(0.0%) 25  
Univen 3 (7.1%) 42  
Age group 
25 or less 3 (7.9%) 38 χ2=1.398, p=0.497 
25-45 2 (3.6%) 55  
Above 45 1 (2.6%) 38  
Gender 
Male 4 (8.0%) 50 χ2=2.314, p=0.128 
Female 2 (2.4%) 84  
Marital status 
Single 3 (4.0%) 75 χ2= 1.674, p= 0.643 
Married 2(4.8%) 42  
Divorced 1 (12.5%) 8  
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Widowed 0 (0.0%) 9  
Infected in 
Vhembe 
NO 1 (11.1%) 9 χ2= 1.985, p= 0.159 
YES 2 (2.4%) 84  
Year of 
recruitment 
2010 5 (4.9%) 103 χ2= 0.000, p= 0.995 
2011 2 (4.9%) 41  
WAZ-2 
Not underweight 5(4.1%) 121 χ2= 1.185, p= 0.276 
Under weight 1 (12.5%) 8  
Prophylaxis 
NO 3 (4.8%) 62 χ2= 1.599, p=0.206 
YES 0 (0.0%) 32  
 
The prevalence of T. gondii IgM in HIV patients taking ARV’S and the CD4 status of the study population 
 
Toxoplasma gondii IgM was more prevalent in patients taking ARV’s compared to those who were not on ARV’s. 
Different types of ARV's were used by the patients on medications. These included: stavudine, lamivudine, tenofovir, 
efavirenz, tenofovir and nevirapine. Toxoplasma IgM antibodies were found to be high in patients who were not on ARV’s 
than those who were adhering to treatment. Toxoplasma gondii IgM antibodies were not detected in patients using 
alternative medication and bactrim. While statistically insignificant, the Toxo-IgM seroprevalence was higher among 
patients whose CD4 was less than 50 cell/mm3 (7.1%) compared to those who had a CD4 level more than 50 cells/mm3. No 
significant difference was observed between the CD4 level (less than 50) and T. gondii IgM titer [Table 7]. 
 
Table 7: The prevalence of Toxoplasma gondii (IgM) in HIV patients taking different ARV’s and the CD4 status the 
patients. 
Variables Characteristics Toxo IgM Positive Total Statistics 
ARV 
NO 1 (2.3%) 44 χ2=0.226, p=0.635 
YES 2 (4.0%) 50  
Zidovudine 
NO 1 (2.2%) 45 χ2=2.932, p=0.087 
YES 1 (16.7%) 6  
Efavirenz                             
NO 1 (7.7%) 13 χ2=0.658, p=0.417 
YES 1 (2.6%) 38  
Lamivudine 
NO 0(0.0%) 2 χ2=0.085, p=0.771 
YES 2 (4.1%) 49  
Tenofovir 
NO 2(6.7%) 30 χ2=1.457, p=0.227 
YES 0 (0.0%) 21  
Nevirapine 
NO 1 (2.4%) 42 χ2=1.499, p=0.221 
YES 1 (11.1%) 9  
Alternative medicine 
NO 3 (3.3%) 91 χ2= 0.102, p=0.749 
YES 0 (0.0%) 3  
Bactrim 
NO 3 (4.0%) 75 χ2=0.785, p=0.376 
YES 0 (0.0%) 19  
Diarrhea at ARV start 
NO 2 (4.1%) 49 χ2=0.127, p=0.721 
YES 0 (0.0%) 3  
CD4 less than 50 
NO 1 (1.4%) 72 χ2=1.708, p=0.191 
YES 1 (7.1%) 14  
CD4 count Less Than 200 
NO 1 (2.3%) 43 χ2=0.000, p=1.000 
YES 1 (2.3%) 43  
CD4 More than 300 
NO 1 (1.7%) 58 χ2=0.284, p=0.594 
YES 1(3.6%) 28  
 
 
The prevalence of T. gondii IgM in patients keeping domestic animals in the households 
 
Toxoplasma gondii IgM antibodies were higher in patients keeping domestic animals in the households. The 
patients who had chickens were more infected than those who were not with no chickens. Moreover, patients who had goats 
and cattles had a higher prevalence of T. gondii IgM [Table 8]. 
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Table 8: The prevalence of T. gondii IgM in patients who keep animals in their houses 
 
Variables Characteristics Toxo IgM Positive Total Statistics 
Animals in house 
NO 5 (4.4%) 114 χ2= 0.001, p=0.973 
YES 1(4.5%) 22  
Chicken 
NO 6 (4.8%) 125 χ2= 0.205, p=0.651 
YES 1(7.7%) 13  
Cattle 
NO 6(4.5%) 133 χ2=2.401, p= 0.121 
YES 1(20.0%) 5  
Dogs 
NO 6 (4.6%) 131 χ2=1.300, p=0.254 
YES 1 (14.3%) 7  
Cats 
NO 7(5.1%) 138  
YES 0 0  
Goats 
NO 6 (4.5%) 134 χ2=3.397, p=0.065 
YES 1 (25.0%) 4  
 
The prevalence of T. gondii IgM in relation to water sources and the quality of water 
 
In terms of water usage, the patients who were using water from rivers and streams were be more infected by T. 
gondii (33.3%). Furthermore, those who were using water from communal tap had a prevalence of 4.9% [Table 9]. No 
statistically significant difference was noted between those using tap water as opposed to the group of patients using water 
from the river/borehole. A high prevalence of T. gondii IgM antibodies was detected in patients using water from untreated 
source compared to the group of patients using water from treated sources (P=0.311). Very few patients were treating their 
water before use, about 4.5% of T. gondii IgM was detected in patients who were not treating their water and the difference 
was not statistically significant (p>0.05). In terms of water storage, the patients who stored water for 2 days or less 
appeared to be more infected (4.7%) and there was no difference between the prevalence of T. gondii among patients who 
stored water for 3 to 5 days and more than 5 days, the difference was also not statistically significant. 
 
Table 9:  The prevalence of T. gondii in relation to water source and the quality of water. 
Variables Characteristics Toxo IgM Positive Total Statistics 
Water source 
Communal tap 5(4.9%) 102 χ2=7.439, p=0.311 
Tap in the house 0 (0.0%) 25  
River/Spring 1 (33.3%) 3  
Borehole 0(0.0%) 6  
Treated Source 
NO 1(11.1%) 9 χ2=1.026, p=0.311 
YES 5 (3.9%) 127  
Do you treat water 
NO 6 (4.5%) 134 χ2=0.094, p=0.760 
YES 0 (0.0%) 2  
Water storage 
Two days or less 4 (4.7%) 85 χ2=0.029, p=0.986 
3 to 5 days 1 (4.2%) 24  
More than 5 days 1 (4.0%) 25  
 
Discussion 
 
Opportunistic infections, with reference to toxoplasmosis are common cause of serious health problems in 
immune-compromised patients, particularly those with HIV and AIDS (Schurer et al., 2016). In the present study, out of 
142 (100 positive and 42 negative) subjects tested, 31.7% were sero-positive for Toxo- IgG antibodies and of the 144 
samples tested, 4.9% were sero-positive for Toxo- IgM antibodies. Our study reported a higher prevalence of T. gondii IgG 
antibodies than the one reported by Bessong and Mathomu, (2010) and by Kistiah et al in (2011).  
This study showed that prevalence of T. gondii IgG was higher in HIV positive patients and low in those who were 
taking ARVs indicating that the use of ARVs might have a positive effect on T. gondii infections. Similar results were 
found in Ethiopia where Muluye et al. (2013) also described a high prevalence of toxoplasma IgG among HIV and AIDS 
patients while the prevalence was lower among HIV negative participants.    
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It was also found that both IgG and IgM antibodies are elevated in patients with high viral load, which cause the 
body to be more susceptible to opportunistic infections. The IgM antibodies prevalence in the study population decreased 
with age. This shows a decline in the infection rate. Similar results were found in a study conducted by Bata et al. (2009). 
Their study showed a high prevalence in patients with age group between 36-45 years. Nijem and Al-Amleh (2009) also 
found the prevalence of toxoplasmosis to be increasing with age and similar results were obtained by another study by 
Rosso et al. (2008). It has been suggested that old people are more likely to have been exposed to any of the risk factors 
than younger people as a results of longer exposure time (Endalew et al., 2012) 
Ingestion of contaminated meat or contact with infected animals (definitive hosts) are some of the risk factors of 
toxoplasmosis (Foroutan-Rad et al., 2016). People become infected after ingesting soil, water or plant material 
contaminated with oocysts. In the present study, many participants agreed that they had animals in their house, but Toxo 
IgG antibodies were less detected in patients who had animals compared to those who didn’t have animals in the house. 
This is to show that most of the patients, who had past infection, probably did not get it from the animals, but about 40% of 
these antibodies were found in patients who had dogs, which might serve as one of the potential risks for toxoplasmosis. 
Similarly, a study in Sri Lanka indicated that animal ownership did not have a significant impact on the seroprevalence of 
Toxoplasma (Chandrasena et al., 2016). In a study in Spain, Cano-Terriza et al. (2016) found a high prevalence of 
Toxoplasma IgG in dogs and the prevalence was associated with the age of the dogs.  
Toxoplasmosis is an important problem among pregnant women presenting the risk of infecting the new born 
child. Fortunately, in the present study, IgM positivity was absent among pregnant women. Similar results have been 
described by Capretti et al. (2014). Over the past five years there has been a significant decrease of toxoplasmosis among 
pregnant women. Similar results were described by Chandrasena et al. (2016). In a study conducted in Saudi Arabia by 
Elsafi et al., (2015), the seroprevalence of toxoplasma among pregnant women were 28% and 3% for IgG and IgM 
respectively while more than 75% of the women were unaware of the disease toxoplasmosis. Education of the community 
members is therefore very important for the implementation of safety measures to reduce infection levels. Contrary to the 
IgG, the IgM antibodies were more detected in patients who had animals in home. This may be an indication of the 
potential differences in the prevalence of exposure to toxoplasmosis and current infection trends. It is possible that people 
who had the animals were at a much higher high risk of current toxoplasmosis. High IgM antibodies were detected in 
patients who had goats, cattle and the seroprevalence rate decreased among those who had dogs. A study in Mexico found a 
high seroprevalence of T. gondii in dogs (Cedillo-Peláez et al., 2012). These results suggest that most of the people who are 
infected are those who come into contact with dogs, cattles and goats. This study also showed that Toxoplasmosis is 
associated with low hygiene, considering its potential transmission by water and food which have been identified as 
important risk factors for the transmission of toxoplasmosis (Pereira et al., 2010). The severity of the infection differs 
among patients depending on host’s immune status and genotypes.  Further studies are needed to determine the circulating 
genotypes in the study population.  
 
Conclusion 
 
Toxoplasmosis is prevalent in the study population. This study has shown that sero-positive status of the patient to 
HIV, high viral load, non-adherence to ARV therapy, age (>25 years) and the presence of infected animals such as dogs, 
cattle and goats are the significant risk factors for toxoplasmosis in this study population. Therefore, people should be 
educated about toxoplasmosis prevention. 
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